---
title: "Entacapone - Parkinson's disease"
sidebar: mydoc_sidebar
permalink: db00494-mesh-d010300-1.html
toc: false 
---


Path ID: `DB00494_MESH_D010300_1`
{% include image.html url="images/db00494-mesh-d010300-1.png" file="db00494-mesh-d010300-1.png" alt="db00494-mesh-d010300-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C071192 | entacapone | Drug |
| UniProt:P21964 | Catechol O-methyltransferase | Protein |
| GO:0102084 | L-dopa O-methyltransferase activity | MolecularActivity |
| CHEBI:15765 | L-dopa | ChemicalSubstance |
| GO:0001963 | synaptic transmission, dopaminergic | BiologicalProcess |
| MESH:D010300 | Parkinson's disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Entacapone | NEGATIVELY REGULATES | Catechol O-Methyltransferase |
| Catechol O-Methyltransferase | POSITIVELY REGULATES | L-Dopa O-Methyltransferase Activity |
| L-Dopa O-Methyltransferase Activity | DECREASES ABUNDANCE OF | L-Dopa |
| L-Dopa | POSITIVELY CORRELATED WITH | Synaptic Transmission, Dopaminergic |
| Synaptic Transmission, Dopaminergic | NEGATIVELY CORRELATED WITH | Parkinson'S Disease |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00494#mechanism-of-action](https://go.drugbank.com/drugs/DB00494#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Entacapone#Mechanism_of_action](https://en.wikipedia.org/wiki/Entacapone#Mechanism_of_action)

Reference: 
  - [https://go.drugbank.com/drugs/DB00494#mechanism-of-action](https://go.drugbank.com/drugs/DB00494#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Entacapone#Mechanism_of_action](https://en.wikipedia.org/wiki/Entacapone#Mechanism_of_action)
